Emerging links between type 2 diabetes and Alzheimer's disease

被引:89
|
作者
Sridhar, Gumpeny R. [1 ]
Lakshmi, Gumpeny [1 ]
Nagamani, Gumpeny [1 ]
机构
[1] Andhra Med Coll, Endocrine & Diabet Ctr, Dept Obstet & Gynecol, Visakhapatnam 530002, Andhra Pradesh, India
来源
WORLD JOURNAL OF DIABETES | 2015年 / 6卷 / 05期
关键词
Cognition; Insulin resistance; Insulin; Butyrylcholinesterase; Dementia;
D O I
10.4239/wjd.v6.i5.744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus and Alzheimer's disease are both associated with increasing age, and each increases the risk of development of the other. Epidemiological, clinical, biochemical and imaging studies have shown that elevated glucose levels and diabetes are associated with cognitive dysfunction, the most prevalent cause of which is Alzheimer's disease. Cross sectional studies have clearly shown such an association, whereas longitudinal studies are equivocal, reflecting the many complex ways in which the two interact. Despite the dichotomy, common risk and etiological factors (obesity, dyslipidemia, insulin resistance, and sedentary habits) are recognized; correction of these by lifestyle changes and pharmacological agents can be expected to prevent or retard the progression of both diseases. Common pathogenic factors in both conditions span a broad sweep including chronic hyperglycemia per se, hyperinsulinemia, insulin resistance, acute hypoglycemic episodes, especially in the elderly, microvascular disease, fibrillar deposits (in brain in Alzheimer's disease and in pancreas in type 2 diabetes), altered insulin processing, inflammation, obesity, dyslipidemia, altered levels of insulin like growth factor and occurrence of variant forms of the protein butyrylcholinesterase. Of interest not only do lifestyle measures have a protective effect against the development of cognitive impairment due to Alzheimer's disease, but so do some of the pharmacological agents used in the treatment of diabetes such as insulin (especially when delivered intranasally), metformin, peroxisome proliferator-activated receptors. agonists, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes must be recognized as a risk for development of Alzheimer's disease; clinicians must ensure preventive care be given to control and postpone both conditions, and to identify cognitive impairment early to manage it appropriately. (C) The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
引用
下载
收藏
页码:744 / 751
页数:8
相关论文
共 50 条
  • [21] Investigations of possible links between Alzheimer’s disease and type 2 diabetes mellitus by positron emission tomography: a systematic review
    Reza Piri
    Mohammad Naghavi-Behzad
    Oke Gerke
    Poul F. Høilund-Carlsen
    Manouchehr Seyedi Vafaee
    Clinical and Translational Imaging, 2019, 7 : 327 - 336
  • [22] Establishing Genomic/Transcriptomic Links Between Alzheimer's Disease and Type 2 Diabetes Mellitus by Meta-Analysis Approach
    Mirza, Zeenat
    Kamal, Mohammad A.
    Buzenadah, Adel M.
    Al-Qahtani, Mohammed H.
    Karim, Sajjad
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (03) : 501 - 516
  • [23] Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimer's Disease?
    Raikwar, Sudhanshu P.
    Bhagavan, Sachin M.
    Ramaswamy, Swathi Beladakere
    Thangavel, Ramasamy
    Dubova, Iuliia
    Selvakumar, Govindhasamy Pushpavathi
    Ahmed, Mohammad Ejaz
    Kempuraj, Duraisamy
    Zaheer, Smita
    Iyer, Shankar
    Zaheer, Asgar
    MOLECULAR NEUROBIOLOGY, 2019, 56 (02) : 833 - 843
  • [24] Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes?
    Mitrea, Adina
    Fallucca, Sara
    Angeletti, Silvia
    Soare, Andreea
    Vernieri, Fabrizio
    Ursini, Francesca
    Trotta, Laura
    Mota, Maria
    Pozzilli, Paolo
    DIABETES, 2014, 63 : A487 - A487
  • [25] Are Tanycytes the Missing Link Between Type 2 Diabetes and Alzheimer’s Disease?
    Sudhanshu P. Raikwar
    Sachin M. Bhagavan
    Swathi Beladakere Ramaswamy
    Ramasamy Thangavel
    Iuliia Dubova
    Govindhasamy Pushpavathi Selvakumar
    Mohammad Ejaz Ahmed
    Duraisamy Kempuraj
    Smita Zaheer
    Shankar Iyer
    Asgar Zaheer
    Molecular Neurobiology, 2019, 56 : 833 - 843
  • [26] Humanin: A Possible Linkage Between Alzheimer's Disease and Type 2 Diabetes
    Mahboobi, Hamidreza
    Golmirzaei, Javad
    Gan, Siew H.
    Jalalian, Mehrdad
    Kamal, Mohammad A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (03) : 543 - 552
  • [27] Investigations of possible links between Alzheimer's disease and type 2 diabetes mellitus by positron emission tomography: a systematic review
    Piri, Reza
    Naghavi-Behzad, Mohammad
    Gerke, Oke
    Hoilund-Carlsen, Poul F.
    Vafaee, Manouchehr Seyedi
    CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (05) : 327 - 336
  • [28] Bioinformatic prediction of the molecular links between Alzheimer's disease and diabetes mellitus
    Castillo-Velazquez, Ricardo
    Martinez-Morales, Flavio
    Castaneda-Delgado, Julio E.
    Garcia-Hernandez, Mariana H.
    Paredes-Sanchez, Francisco A.
    Rivera, Gildardo
    Rivas-Santiago, Bruno
    Lara-Ramirez, Edgar E.
    PEERJ, 2023, 11
  • [29] Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type
    Law, A
    Gauthier, S
    Quirion, R
    BRAIN RESEARCH REVIEWS, 2001, 35 (01) : 73 - 96
  • [30] Type 2 diabetes mellitus and Alzheimer's disease
    Barbagallo, Mario
    Dominguez, Ligia J.
    WORLD JOURNAL OF DIABETES, 2014, 5 (06): : 889 - 893